Type I IFN autoantibodies were not detected in any of the five patients described here, although the limited number of cases presented here precludes any specific conclusion to be drawn concerning the presence and a potential pathogenic role of IFN autoantibodies in the pathogenesis of MIS-A. The gene discussed is IFNA1; the disease is COVID-19–associated multisystem inflammatory syndrome in adults.